Literature DB >> 17511773

Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.

Takashi Fukuyama1, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto.   

Abstract

Cytokines produced by tumor cells may have various effects on antitumor immune responses and tumor growth. In the present study, the cytokine production of 31 lung cancer cell lines was evaluated, while any correlation with the histological type, the induction of tumor-specific cytotoxic T lymphocytes (CTL) in vitro, and angiogenesis and the infiltration of inflammatory cells in tumor tissues were also examined. Production of interleukin (IL)-1alpha, IL-1beta, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor, transforming growth factor (TGF)-beta and vascular endothelial growth factor (VEGF) in the culture supernatant was measured using enzyme-linked immunosorbent assay. Each cytokine was produced in a substantial number of the tumor cell lines. In particular, IL-6, IL-8, TGF-beta and VEGF were produced in 18 (55%), 29 (94%), 31 (100%) and 28 (90%) of 31 cell lines, respectively. However, neither IL-4 nor TNF-alpha was produced at all by any tumor cell line. TGF-beta production was significantly higher in adenocarcinoma than in squamous cell carcinoma (P = 0.03). Immunohistochemical staining revealed the magnitude of macrophage infiltration, and angiogenesis in surgically resected tumor tissue specimens correlated well with GM-CSF and IL-8 production from the corresponding cell lines. Among six lung cancer cell lines, CTL were induced in the three lung cancer cell lines that produced a lower amount of TGF-beta (<100 pg/mL). These findings suggested that TGF-beta produced by tumor cells could inhibit the induction of CTL in vitro. The present results suggest that the production of various cytokines from tumor cells might exert various paracrine effects both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511773     DOI: 10.1111/j.1349-7006.2007.00507.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  33 in total

1.  Development of pulmonary Langerhans cell histiocytosis in a patient with established adenocarcinoma of the lung.

Authors:  Or Kalchiem-Dekel; Adina Paulk; Seth J Kligerman; Allen P Burke; Nirav G Shah; Renee K Dixon
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.

Authors:  Yi Luo; Issam El Naqa; Daniel L McShan; Dipankar Ray; Ines Lohse; Martha M Matuszak; Dawn Owen; Shruti Jolly; Theodore S Lawrence; Feng-Ming Spring Kong; Randall K Ten Haken
Journal:  Radiother Oncol       Date:  2017-02-22       Impact factor: 6.280

3.  Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.

Authors:  Jiong Deng; Junya Fujimoto; Xiao-Feng Ye; Tao-Yan Men; Carolyn S Van Pelt; Yu-Long Chen; Xiao-Feng Lin; Humam Kadara; Qingguo Tao; Dafna Lotan; Reuben Lotan
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-30

4.  Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer.

Authors:  Yi Luo; Daniel McShan; Dipankar Ray; Martha Matuszak; Shruti Jolly; Theodore Lawrence; Feng Ming Kong; Randall Ten Haken; Issam El Naqa
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-05-02

5.  Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.

Authors:  Sharon R Pine; Leah E Mechanic; Lindsey Enewold; Elise D Bowman; Bríd M Ryan; Michele L Cote; Angela S Wenzlaff; Christopher A Loffredo; Susan Olivo-Marston; Anil Chaturvedi; Neil E Caporaso; Ann G Schwartz; Curtis C Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-28       Impact factor: 4.254

6.  Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer.

Authors:  William F Pirl; Lara Traeger; Joseph A Greer; Heather Bemis; Emily Gallagher; Inga Lennes; Lecia Sequist; Rebecca Heist; Jennifer S Temel
Journal:  Oncologist       Date:  2011-08-01

7.  The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

Authors:  Lucy F Stead; Stefano Berri; Henry M Wood; Philip Egan; Caroline Conway; Catherine Daly; Kostas Papagiannopoulos; Pamela Rabbitts
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

8.  Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.

Authors:  Geraldine Chow; Jordi Tauler; James L Mulshine
Journal:  J Biomed Biotechnol       Date:  2010-06-30

9.  Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes.

Authors:  Yoshiki Shigematsu; Takeshi Hanagiri; Hironobu Shiota; Koji Kuroda; Tetsuro Baba; Yoshinobu Ichiki; Manabu Yasuda; Hidetaka Uramoto; Mitsuhiro Takenoyama; Kosei Yasumoto; Fumihiro Tanaka
Journal:  Oncol Lett       Date:  2012-07-20       Impact factor: 2.967

Review 10.  Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.

Authors:  Kosei Yasumoto; Takeshi Hanagiri; Mitsuhiro Takenoyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.